Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study

• Main Authors: Danielle Delombaerde (Author), Johan De Sutter (Author), Lieselot Croes (Author), Delphine Vervloet (Author), Veronique Moerman (Author), Nico Van de Veire (Author), Anne-Marie Willems (Author), Kristien Wouters (Author), Marc Peeters (Author), Hans Prenen (Author), Christof Vulsteke (Author)
• Format: Book
• Published: MDPI AG, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The increasing use of immune checkpoint inhibitors (ICIs) in the treatment of both advanced and early stages of various malignancies has resulted in a substantial increase in the incidence of cardiovascular (CV) immune-related adverse events (irAEs). The current follow-up guidelines are...